The anti-tumor function of T cells in TME may be suppressed by the FOXP3+ regulatory T cells (Treg) activity or by the PD-1 (programmed cell death 1)/PD-L1 (PD-1 ligand) interactions [14]. The gene discussed is PDCD1; the disease is neoplasm.